A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.
about
Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancerNedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancerSNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancerOxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study.A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance.Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.Trial Watch: Chemotherapy with immunogenic cell death inducers.
P2860
Q28540917-761945E1-FBCB-4CAE-9D78-27A85D6D771CQ34852774-87366A28-F861-4142-988F-842E2E91CFB3Q35498689-94B3023C-217F-419E-8957-09489A5FD6CDQ35858069-6F3A8348-4751-425C-9302-0809B9EFFC04Q36896065-1EE669C1-72B9-4BD4-9772-7592EA79CB92Q38713515-B9DFA129-C4D5-4B77-8FD5-AB536372ADF9Q38746249-5DDC1173-BDDD-4F3C-ABC6-D490B4EE0882Q38887635-30294930-4B90-4BAA-88BF-9E71B090FD08Q38971333-88573575-D483-4156-8ABA-CF574AD94B74Q46031627-0F90B7E6-4641-410F-AB86-9EF1054721EFQ55260834-984B0D93-D402-4C6C-8B8B-1FA9A5E56C4B
P2860
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A randomised multicentre phase ...... ic non-small cell lung cancer.
@ast
A randomised multicentre phase ...... ic non-small cell lung cancer.
@en
type
label
A randomised multicentre phase ...... ic non-small cell lung cancer.
@ast
A randomised multicentre phase ...... ic non-small cell lung cancer.
@en
prefLabel
A randomised multicentre phase ...... ic non-small cell lung cancer.
@ast
A randomised multicentre phase ...... ic non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
A randomised multicentre phase ...... ic non-small cell lung cancer.
@en
P2093
F Kullmann
G Dingeldein
H Bernhard
H Günther Derigs
P2860
P2888
P304
P356
10.1038/BJC.2012.555
P407
P577
2013-01-17T00:00:00Z